News | September 09, 2008

Carestream Molecular Imaging Expands Global Presence

September 10 — Carestream Molecular Imaging, a division of Carestream Health, Inc.is expanding its international presence with new dealer partnerships and a growing worldwide customer base, adding new dealer partners in Europe and the Middle East, the company reported at this week’s World Molecular Imaging Conference in Nice, France.

As part of its strategy to fill the demand for a cost effective and translatable molecular imaging solutions, the molecular imaging division has established new dealer partnerships with BioNova Cientifica, S.l. in Spain, Biosense S.R.L. in Italy, Csertex KFT in Hungary, and TransOrient Trading Co. in Palestine.

The company’s European dealer network is dedicated to increasing the presence of the company’s optical molecular imaging systems and fluorescent imaging agents to prominent pharmaceutical companies and research institutions. Partners such as Advanced Molecular Vision Ltd., AMV Germany, BioTech a.s., Csertex Ltd., Metis Biyoteknoloji and Metis-Turkey have been instrumental in the company’s recent customer successes in the following European institutions, such as Baxter AG, Charles University of Prague, Imperial College London’s Kennedy Institute of Rheumatology and several others.

Carestream Molecular Imaging is showcasing its portfolio of in vivo digital molecular imaging systems and imaging agents at the 2008 World Molecular Imaging Conference.
Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

For more information: mi.carestreamhealth.com

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.